Filing metadata

Accession number
0001415889-25-006684
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Mar 04, 2025
Reporting period
Feb 28, 2025
Description
Insider transaction

Explore SEC Filings Hub